← Back
Data updated: Mar 29, 2026
NESHER PHARMS
Infectious DiseaseOncologyCardiovascular
Generics
NESHER PHARMS is a generic drug manufacturer focused on Infectious Disease, Oncology, Cardiovascular.
1980
Since
24
Drugs
-
Trials
598
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
NYSTATIN 2026-02-05
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
DILTIAZEM HYDROCHLORIDE 2026-01-24
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 31%
1 drugs Phase 3: 1 Phase 2: 2
Oncology 31%
0 drugs Phase 3: 3 Phase 1: 2
Cardiovascular 27%
2 drugs
Dermatology 11%
0 drugs Phase 3: 1 Phase 1: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Dermatology
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
COSETTE other
Cardiovascular, Dermatology, Infectious Disease, Oncology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology, Cardiovascular
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular
Active (9)
Discontinued (15)
DILTIAZEM HYDROCHLORIDE OXYCODONE AND ACETAMINOPHEN HYDROCODONE BITARTRATE AND ACETAMINOPHEN OXYCODONE HYDROCHLORIDE POTASSIUM CHLORIDE MORPHINE SULFATE ONDANSETRON PREDNISOLONE SODIUM PHOSPHATE METOPROLOL SUCCINATE DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE PREDNISOLONE BENZONATATE MICRO-K MICRO-K 10 DISOPYRAMIDE PHOSPHATE
Company Info
- First Approval
- 1980-10-17
- Latest
- 2022-02-25
- Applications
- 33